December 20, 2018
We specialize in neuromuscular and rare disease clinical trials. The science is fascinating, but there are a lot more complexities than in other types of clinical trials. Many neuromuscular and other rare diseases have genetic causes, which makes everything even more complicated.
It’s important to design your clinical trial protocols to minimize variability in your study population up front. For many TRiNDS studies, that means confirming participants’ genotypes during study screening. Whether you’re testing an investigational product that acts at the DNA or RNA level, or if you need to exclude certain diagnostic subtypes, having expert help is critical.
We offer central diagnostic confirmation services to research projects and all phases of clinical trials. Our licensed genetic counselors combine their clinical training and research expertise to provide consistent review and analysis of test results. After informed consent, sites or central laboratories submit de – identified reports to our team for review. Our genetic counselors interpret the results and inform the site and the medical monitoring team of the participant’s eligibility for the study.
Contact us to request a quote for central diagnostic confirmation services.